Hw. Yu et al., Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome, HUM MOL GEN, 9(9), 2000, pp. 1385-1391
The Smith-Lemli-Opitz syndrome (SLOS; also known as the RSH syndrome) is an
autosomal recessive genetic disorder, leading to characteristic multi-orga
n developmental abnormalities, dysmorphic facies, limb malformations and me
ntal retardation. Mutations in the gene for Delta(7)-dehydrocholesterol red
uctase (Delta(7)-reductase), which catalyzes the last step in cholesterol b
iosynthesis, cause the disease. We screened 32 patients with SLOS, 28 from
the USA and four from Sweden. Twenty-two different nucleotide changes, pred
icted to be disease-causing mutations, were identified; 20 missense mutatio
ns, one nonsense mutation and one splice-site mutation involving the exon 9
acceptor site (IVS8 -1G-->C) were detected. All probands were heterozygous
for mutations. Twelve of these mutations have not been reported previously
, including missense mutations L148R, F168I, D175H, P179L, P243R, F284L, N2
87K, F302L, R404S, Y462H, R469P and one nonsense mutation E37X. Coupled wit
h previously reported mutations, these findings bring the total of differen
t Delta(7)-reductase mutations to 36. These are distributed throughout the
coding sequence of the Delta 7-reductase gene except exons 3 and 5, with a
clustering in exon 9. Three mutations account for 54% of those observed in
our cohort, the splice acceptor site mutation IVS8 -1G-->C (22/64 alleles,
34%), T93M (8/64, 12.5%) and V326L (5/64, 7.8%). Severity of SLOS was negat
ively correlated with both plasma cholesterol and relative plasma cholester
ol, but not with 7-dehydrocholesterol, the immediate precursor, confirming
previous observations. However, no correlation was observed between mutatio
ns and phenotype, suggesting that the degree of severity may be affected by
other factors. We estimate that between 33 and 42% of the variation in the
SLOS severity score is accounted for by variation in plasma cholesterol. T
hus, factors other than plasma cholesterol are additionally involved in det
ermining severity.